ArticleCancers2019

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer.

Letizia Porcelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.